Dr Reddys Laboratories (RDY) Goodwill & Intangibles (2009 - 2026)

Dr Reddys Laboratories (RDY) has reported Goodwill & Intangibles for 18 consecutive years, with $1.3 billion the latest figure, recorded in Q1 2026.

• Quarterly Goodwill & Intangibles fell 1.18% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (down 1.18% YoY) and the FY2026 annual result came in at $1.3 billion, down 1.18% from the prior year.
• Goodwill & Intangibles eased to $1.3 billion in Q1 2026 per RDY's latest filing, from $1.3 billion in the prior quarter.
• Over the last five years, Goodwill & Intangibles for RDY reached as high as $1.3 billion in Q1 2025 and fell as low as $417.0 million in Q1 2022.
• A 5-year average of $689.3 million and a median of $494.0 million in 2024 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles retreated 24.04% — and 2025, when it soared 157.49%.
• Year by year, Goodwill & Intangibles stood at $441.0 million in 2022, then gained by 17.01% to $516.0 million in 2023, then fell by 4.26% to $494.0 million in 2024, then surged by 157.49% to $1.3 billion in 2025, then decreased by 1.18% to $1.3 billion in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $1.3 billion, $1.3 billion, and $494.0 million for Q1 2026, Q1 2025, and Q1 2024 respectively.